Developing soft wireless devices to study heart failure
Official title: Soft wireless multimodal cardiac implantable devices for long-term investigating heart failure pathogenesis
Funded at George Washington University · NIH-10865017 · Data updated 2026-11-12
This study is testing a new soft device that can be placed inside the body to wirelessly keep track of heart activity and help understand how heart failure affects the heart over time, all while allowing animals to move freely.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $541,251 |
| NIH project number | 5R01HL166746-02 |
| Project ID | NIH-10865017 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with chronic heart failure or those at risk of developing heart failure.
✕Less likely to help
Patients with acute heart conditions or those who do not have heart failure may not benefit from this research.
What this research studies
This research focuses on creating a soft, fully implantable device that can wirelessly monitor and modulate heart activity. By using this innovative technology, researchers aim to observe and understand the chronic changes in heart function and metabolism that occur during heart failure. The device will be tested in live animals to gather detailed data on heart conditions without restricting movement, which is crucial for accurate results. This approach will help uncover the complex mechanisms behind heart failure and improve treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for heart failure patients.
How similar studies have gone: While the approach is innovative, similar technologies have shown promise in other areas of cardiac research, indicating potential for success.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Lu, Luyao — George Washington University
- Study coordinator: Lu, Luyao
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Digital-first heart failure care delivery in Uganda
A targeted program in Uganda tests a digital care plan to help people with heart failure manage their symptoms at home.
-
Digital-first heart failure care delivery in Uganda
A study to test digital self-care tools to help people with heart failure in Uganda manage symptoms and stay healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.